Why Drug Companies are Looking to Space for New Medicines

High above the Earth, about 300 miles away, three small capsules are currently orbiting our planet. These machines, each about the size of a washing machine, are not just floating in space for fun. Inside one of them, scientists are growing tiny crystals that could one day become a powerful new cancer drug. This project is a major step toward a new and potentially profitable industry: making medicine in space.

The company behind this project is Varda Space Industries, based in California. According to The Guardian Health, the company launched two of these capsules on October 1st and a third one on October 20th. This is the first time a company has had three spacecraft in orbit at the same time for this purpose. Will Bruey, the chief executive of Varda, said that while this idea once seemed like a dream for the future, it is now becoming a reality as the number of launches increases.

Why would a company want to make medicine in space instead of on Earth? The answer lies in a condition called microgravity—a state where there is very little gravity. On Earth, gravity causes particles in liquids to settle at the bottom, and it creates currents that move liquids around. These natural forces can make it difficult to grow perfect crystals. When scientists grow crystals in space, they can avoid these problems. Dr. Meganne Christian, a mission manager at the UK-based Satellite Applications Catapult, explained that without the interference of gravity, crystals can grow in a much more organized and perfect way.

This is very important for pharmaceutical companies. The way a drug crystal is shaped and arranged can change how well the medicine works. It affects how easily a drug dissolves in the body, how long it stays stable, and how it is given to a patient. If scientists can make better crystals in space, they might be able to change some medicines that currently require long hospital stays for intravenous infusions—where medicine is given through a tube into a vein—into simple injections that patients can give themselves at home.

Medicine is not the only thing that could be made in space. Other materials, such as semiconductors used in smartphones and electric cars, could also benefit from this process. Dr. Christian noted that materials like graphene, which is very strong and useful, often have defects when made on Earth. By making these materials in microgravity, companies could produce much higher-performing products with fewer errors.

Scientists have been studying these processes for decades, mostly on the International Space Station (ISS). However, the ISS was not built for large-scale manufacturing. Dr. Ryan Reeves, a scientist for the ISS National Laboratory, explained that the station was designed as a place for scientific experiments, not as a factory. Furthermore, the ISS is expected to be retired around 2030. Because of this, several companies are now working to build their own commercial space stations and specialized laboratories to take over the work.

One example is the UK-based company BioOrbit. They recently sent a small laboratory to the ISS to test the production of cancer drugs that patients could inject themselves. However, experts point out that there are still challenges to overcome. For large-scale production, companies need to find ways to run these factories without humans present. Humans can introduce dirt or other contaminants into the sensitive environment, which could ruin the delicate crystal-growing process. Therefore, the goal is to create automated systems that can work alone in space.

As these companies continue to test their technology, the dream of "space manufacturing" is moving closer to reality. While it is still a new field, the potential benefits for patients are significant. If researchers can successfully create more stable and effective drugs in the weightless environment of orbit, it could change the way we treat many serious diseases. For now, the world is watching these small capsules as they orbit the Earth, waiting to see if they can bring back the breakthrough medicines of the future.